Regulation of macrophage functions by PPAR-α, PPAR-γ, and LXRs in mice and men

被引:247
作者
Rigamonti, Elena
Chinetti-Gbaguidi, Giulia
Staels, Bart
机构
[1] Inst Pasteur, INSERM, U545, F-59019 Lille, France
[2] Univ Lille 2, Fac Pharm & Med, Lille, France
关键词
nuclear receptors; atherosclerosis; lipid metabolism; inflammation;
D O I
10.1161/ATVBAHA.107.158998
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Peroxisome proliferator-activated receptors (PPARs) and (liver X receptors) LXRs are ligand-activated transcription factors that control lipid and glucose metabolism, as well as the inflammatory response. Because the macrophage plays an important role in host defense and immunoinflammatory pathologies, particular attention has been paid to the role of PPARs and LXRs in the control of macrophage gene expression and function. Research over the last few years has revealed important roles for PPAR-alpha, PPAR-gamma, and LXRs in macrophage inflammation and cholesterol homeostasis with consequences for atherosclerosis development. In this review we will discuss the role of these transcription factors in the control of macrophage activities, with particular attention to species-differences in macrophage function control by PPARs and LXR between rodents and humans.
引用
收藏
页码:1050 / 1059
页数:10
相关论文
共 119 条
[21]  
Chiu B, 1997, CIRCULATION, V96, P2144
[22]   Oxidized low density lipoprotein inhibits interleukin-12 production in lipopolysaccharide-activated mouse macrophages via direct interactions between peroxisome proliferator-activated receptor-γ and nuclear factor-κB [J].
Chung, SW ;
Kang, BY ;
Kim, SH ;
Pak, YK ;
Cho, D ;
Trinchieri, G ;
Kim, TS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (42) :32681-32687
[23]   PPARγ promotes mannose receptor gene expression in murine macrophages and contributes to the induction of this receptor by IL-13 [J].
Coste, A ;
Dubourdeau, M ;
Linas, MD ;
Cassaing, S ;
Lepert, JC ;
Balard, P ;
Chalmeton, S ;
Bernad, J ;
Orfila, C ;
Séguéla, JP ;
Pipy, B .
IMMUNITY, 2003, 19 (03) :329-339
[24]  
Costet P, 2000, J BIOL CHEM, V275, P28240
[25]   Functional expression and characterization of the human ABCG1 and ABCG4 proteins:: indications for heterodimerization [J].
Cserepes, J ;
Szentpétery, Z ;
Seres, L ;
Özvegy-Laczka, C ;
Langmann, T ;
Schmitz, G ;
Glavinas, H ;
Klein, I ;
Glavinas, H ;
Klein, I ;
Homolya, L ;
Váradi, A ;
Sarkadi, B ;
Elkind, NB .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 320 (03) :860-867
[26]   Atherosclerosis: cell biology and lipoproteins [J].
Daugherty, Alan ;
Rateri, Debra L. .
CURRENT OPINION IN LIPIDOLOGY, 2006, 17 (06) :705-707
[27]   Oxidized phospholipids activate PPARα in a phospholipase A2-dependent manner [J].
Delerive, P ;
Furman, C ;
Teissier, E ;
Fruchart, JC ;
Duriez, P ;
Staels, B .
FEBS LETTERS, 2000, 471 (01) :34-38
[28]   Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor γ (BPARγ) heterodimer:: A basis for new therapeutic strategies [J].
Desreumaux, P ;
Dubuquoy, L ;
Nutten, S ;
Peuchmaur, M ;
Englaro, W ;
Schoonjans, K ;
Derijard, B ;
Desvergne, B ;
Wahli, W ;
Chambon, P ;
Leibowitz, MD ;
Colombel, JF ;
Auwerx, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (07) :827-838
[29]   The PPAR alpha-leukotriene B-4 pathway to inflammation control [J].
Devchand, PR ;
Keller, H ;
Peters, JM ;
Vazquez, M ;
Gonzalez, FJ ;
Wahli, W .
NATURE, 1996, 384 (6604) :39-43
[30]   Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events):: a randomised controlled trial [J].
Dormandy, JA ;
Charbonnel, B ;
Eckland, DJA ;
Erdmann, E ;
Massi-Benedetti, M ;
Kmoules, IK ;
Skene, AM ;
Tan, MH ;
Lefébvre, PJ ;
Murray, GD ;
Standl, E ;
Wilcox, RG ;
Wlhelmsen, L ;
Betteridge, J ;
Birkeland, K ;
Golay, A ;
Heine, RJ ;
Korányi, L ;
Laakso, M ;
Mokán, M ;
Norkus, A ;
Pirags, V ;
Podar, T ;
Scheen, A ;
Scherbaum, W ;
Schernthaner, G ;
Schmitz, O ;
Skrha, J ;
Smith, U ;
Taton, J .
LANCET, 2005, 366 (9493) :1279-1289